Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Shared Hospital Services (AMS) Cash & Equivalents (2016 - 2025)

American Shared Hospital Services has reported Cash & Equivalents over the past 16 years, most recently at $3.5 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $3.5 million for Q4 2025, up 1284.8% from a year ago — trailing twelve months through Dec 2025 was $3.5 million (up 1284.8% YoY), and the annual figure for FY2025 was $3.5 million, up 1284.8%.
  • Cash & Equivalents for Q4 2025 was $3.5 million at American Shared Hospital Services, down from $5.1 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for AMS hit a ceiling of $14.5 million in Q3 2023 and a floor of $118000.0 in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $9.8 million (2021), compared with a mean of $8.8 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 98.55% in 2022 and later skyrocketed 11501.69% in 2023.
  • American Shared Hospital Services' Cash & Equivalents stood at $8.1 million in 2021, then tumbled by 98.55% to $118000.0 in 2022, then skyrocketed by 11501.69% to $13.7 million in 2023, then tumbled by 98.17% to $250000.0 in 2024, then soared by 1284.8% to $3.5 million in 2025.
  • The last three reported values for Cash & Equivalents were $3.5 million (Q4 2025), $5.1 million (Q3 2025), and $250000.0 (Q2 2025) per Business Quant data.